课题基金 / 基金详情

项目摘要

项目成果

ETHAN A MERRITT的其他基金

相似基金

相关文献

中文摘要
翻译

英文摘要
 DESCRIPTION (provided by applicant): The universally essential enzyme prolyl-tRNA synthetase (ProRS) has recently been identified as a molecular target for the drug halofuginone, which is derived from natural products with anti-malarial activity. Halofuginone exhibits a conserved mode of binding to both plasmodium and human ProRS as shown by crystal structures of the respective drug:enzyme complexes. We have shown that halofuginone is also blocks growth and encystation of Giardia in culture with an EC50 approximately equal to that of the current front line anti-giardiasis drug metronidazole. Nevertheless the active site of ProRS from Giardia and from Trichomonas species differs significantly from that of the human and plasmodium homologs, as we have shown by sequence analysis and by determining a Giardia ProRS crystal structure. This strongly suggests that suitable modification of halofuginone will both increase its potency and its specificity of action against Giardia and Trichomonas parasites relative to the human host. We will evaluate such compounds for activity in suppressing parasite growth, cell attachment, or encystation. A primary goal is to use SAR-guided synthetic chemistry to develop compounds that are orally bioavailable, sufficiently potent, lack toxicity, and cure animal models of Giardia infection. By the end of this project we expect to have lead compounds for evaluation as new drugs against giardiasis and trichomoniasis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Novel Therapeutics Targeting Giardia Kinases
  • 批准号:
    9221721
  • 项目类别:
  • 资助金额:
    $19.34万
  • 财政年份:
    2016
  • 负责人:
    ETHAN A MERRITT
  • 依托单位:
MEDICAL STRUCTURAL GENOMICS OF PATHOGENIC PROTOZOA
  • 批准号:
    8362112
  • 项目类别:
  • 资助金额:
    $0.22万
  • 财政年份:
    2011
  • 负责人:
    ETHAN A MERRITT
  • 依托单位:
MEDICAL STRUCTURAL GENOMICS OF PATHOGENIC PROTOZOA
  • 批准号:
    8362415
  • 项目类别:
  • 资助金额:
    $0.06万
  • 财政年份:
    2011
  • 负责人:
    ETHAN A MERRITT
  • 依托单位:
Calcium Dependent Protein Kinase 1 as a drug target for T. gondii and C. parvum
  • 批准号:
    7937610
  • 项目类别:
  • 资助金额:
    $105.13万
  • 财政年份:
    2010
  • 负责人:
    ETHAN A MERRITT
  • 依托单位:
海外基金